Latest News in the pharma Industry

Top Stories

Pfizer and Allergan to combine

Pfizer and Allergan to combine

23 Nov 2015

As a result of the combination with Allergan and subsequent integration of the two companies, Pfizer now expects to make a decision about a potential separation of the combined company's innovative and established businesses by no later than the end of...

Read more 
BMS to sell its HIV R&D portfolio to ViiV Healthcare

BMS to sell its HIV R&D portfolio to ViiV Healthcare

18 Dec 2015

Transactions are consistent with the evolution of BMS’s strategic focus, including the decision to discontinue its discovery efforts in virology announced in June.

Read more 
Catalent working to re-start production at French facility

Catalent working to re-start production at French facility

16 Nov 2015

Company’s preliminary investigation indicates tha the incidents of out-of-place softgel capsules in several product batches could be related to a deliberate action by one or more individuals.

Read more 
Perrigo shareholders convincingly reject Mylan's tender offer, expressing confidence in Perrigo's long-term strategy

Perrigo shareholders convincingly reject Mylan's tender offer, expressing confidence in Perrigo's long-term strategy

13 Nov 2015

Perrigo will immediately commence its previously announced $2 billion repurchase of Perrigo shares and plans to complete $500 million of the planned repurchase by the end of 2015.

Read more 
Roche to restructure its manufacturing network for small molecules

Roche to restructure its manufacturing network for small molecules

13 Nov 2015

Exiting four sites to optimise capacity utilisation will affect approximately 1,200 positions.

Read more 
Sanofi Pasteur reveals its research on a ”universal” influenza vaccine

Sanofi Pasteur reveals its research on a ”universal” influenza vaccine

9 Nov 2015

The vaccines division of Sanofi presents at the World Vaccine Congress in Spain.

Read more 
Eli Lilly announces expansion of Indianapolis R&D headquarters

Eli Lilly announces expansion of Indianapolis R&D headquarters

2 Nov 2015

New building to feature collaboration-focused workspace.

Read more 
Biogen Q3 2015 revenues increase 11% to $2.8 billion

Biogen Q3 2015 revenues increase 11% to $2.8 billion

22 Oct 2015

Corporate restructuring to result in an 11% workforce reduction.

Read more 
Lilly to discontinue development of evacetrapib for high-risk atherosclerotic cardiovascular disease

Lilly to discontinue development of evacetrapib for high-risk atherosclerotic cardiovascular disease

12 Oct 2015

Phase III trial terminated due to insufficient efficacy.

Read more 
NIH grantees win 2015 Nobel Prize in chemistry

NIH grantees win 2015 Nobel Prize in chemistry

7 Oct 2015

Prize awarded for mapping, at a molecular level, how cells repair damaged DNA and safeguard the genetic information.

Read more 
FTC files amicus brief explaining that pharmaceutical “product hopping” can violate the antitrust laws

FTC files amicus brief explaining that pharmaceutical “product hopping” can violate the antitrust laws

2 Oct 2015

The FTC filed its amicus brief in a private antitrust action in which Mylan Phamraceuticals Inc. alleges that Warner Chilcott PLC/Mayne Pharma Group maintained a monopoly in the market for its antibiotic Doryx by suppressing generic competition through...

Read more 
National Biologics Manufacturing Centre launched

National Biologics Manufacturing Centre launched

1 Oct 2015

The new centre will provide companies with open access facilities and expertise to help them develop, prove and commercialise new and improved processes and technologies for biologics manufacture.

Read more